Abstract:The asymmetric unit of the title compound, C14H13NO4, contains three independent mol-ecules, which differ slightly in conformation. Each contains an intra-molecular N-H⋯O hydrogen bond. In the crystal, O-H⋯O hydrogen bonds form chains of mol-ecules, which are linked into corrugated sheets parallel to (03) plane by C-H⋯O hydrogen bonds together with π inter-actions between the carbonyl groups and the 2-hy-droxy-phenyl rings. The layers are linked by further C-H⋯O hydrogen bonds. The Hirshfeld surface analysis of the crystal structure indicates that the most important contributions for the crystal packing are from H⋯H (49.0%), H⋯O/O⋯H (28.3%) and H⋯C/C⋯H (10.9%) inter-actions. van der Waals inter-actions are the dominant inter-actions in the crystal packing. Moreover, density functional theory (DFT) optimized structures at the B3LYP/ 6-311 G(d,p) level are compared with the experimentally determined mol-ecular structure in the solid state. The HOMO-LUMO behavior was elucidated to determine the energy gap of 4.53 eV.

Crystal structure of gepirone, C 19 H 29 N 5 O 2

Crystal Structure of 5-(4-pyridyl)pyrimidine–4,4′-bipyridine–1,3,5-benzenetriol–water (1:1:1:1), C25H23N5O4

Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Crystal structure of cariprazine dihydrochloride, C 21 H 34 Cl 2 N 4 OCl 2

Crystal structure of 2,5-bis(2,5-dimethoxybenzyl)-3,6-dimethyl-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, C 26 H 28 N 2 O 6

Structures of 3,6-bis(3-chlorophenyl)pyrrolo[3,4-c]pyrrole-1,4-dione and 3,6-bis(4-chlorophenyl)pyrrolo[3,4-c]pyrrole-1,4-dione

The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1 H -pyrrole-2,5-dione, C 21 H 22 N 2 O 2

Crystal Structure of a Novel 1,2,4- Triazolo[4,3- a ]pyridine Compound with Antifungal Activity

Crystal structure of N , N -bis(2,5-dioxopyrrolidin-1-ylmethyl)glycine

The crystal structure of ( Z )-5-amino- N ′ -hydroxy-1 H -pyrazole-4-carboximidamide, C 4 H 7 N 5 O

The crystal structure of 2-(2-((4,6-dimethoxypyrimidin-2-yl)oxy)phenyl)-4-(piperidin-1-yl)-5 H -chromeno[2,3- d ]pyrimidine, C 28 H 27 N 5 O 4

Crystal structure of 3-(difluoromethyl)-1-methyl- N -(pyridin-2-yl)-1 H -pyrazole-4-carboxamide, C 11 H 10 F 2 N 4 O

The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C 37 H 37 BN 2 O 4

Crystalline Forms of 4,4'-Methylenediantipyrine: Crystallographic Unit Cell for the Anhydrous Form, from Laboratory Powder XRD Pattern by DASH Program Package

Crystal structure of 1–methyl-3-propyl-4-nitro-1H-pyrazole-5-carboxylic acid, C 8 H 11 N 3 O 4

Crystal structure of ( E )- N -(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C 26 H 22 BrN 3 O 3

Crystal structure, Hirshfeld surface analysis and DFT calculations of (E)-3-[1-(2-hy-droxy-phenyl-anilino)ethyl-idene]-6-methyl-pyran-2,4-dione

The crystal structure of 2,5-bis[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1 H -pyrazol-4-yl)amino]cyclohexa-2,5-diene-1,4-dione, C 28 H 26 N 6 O 4

Crystal structure of (3,6-di(2-pyridyl)-4-phenylaminopyridazine-κ 2 N,N′)-bis(2-(p-toluene)pyridinyl-κ 2 C,N)-iridium(III) hexafluorophosphate –dichloromethane (1/1), C 45 H 37 Cl 2 F 6 IrN 7 P